All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Tirzepatide 5mg: Weight Loss Average

Average weight loss on tirzepatide 5mg based on clinical trial data. Learn realistic expectations, how results compare to higher doses, and factors...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Tirzepatide 5mg: Weight Loss Average custom 2026 header image for GLP-1 Weight Loss
Custom header image for Tirzepatide 5mg: Weight Loss Average, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Tirzepatide 5mg: Weight Loss Average

Average weight loss on tirzepatide 5mg based on clinical trial data. Learn realistic expectations, how results compare to higher doses, and factors...

Short answer

Average weight loss on tirzepatide 5mg based on clinical trial data. Learn realistic expectations, how results compare to higher doses, and factors...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Average weight loss on tirzepatide 5mg based on clinical trial data. Learn realistic expectations, how results compare to higher doses, and factors that influence individual outcomes.

The average weight loss on tirzepatide 5mg is approximately 15 percent of starting body weight over 72 weeks, according to the SURMOUNT-1[1] clinical trial. For a 220-pound patient, that translates to roughly 33 pounds. For a 180-pound patient, approximately 27 pounds. These are averages, and individual results vary based on diet, exercise, and metabolic factors.

Clinical Trial Data: The Numbers

The strongest evidence for tirzepatide 5mg weight loss comes from two major trial programs:

SURMOUNT-1 (Weight Management): This trial enrolled adults with obesity or overweight with at least one weight-related comorbidity but without type 2 diabetes. Participants on tirzepatide 5mg lost an average of 15.0 percent of their body weight at 72 weeks compared to 3.1 percent in the placebo group.

SURPASS trials (Type 2 Diabetes): In patients with type 2 diabetes, tirzepatide 5mg produced average weight loss of 7 to 9 percent of body weight at 40 to 52 weeks. Weight loss in diabetes patients is typically lower than in non-diabetic patients due to metabolic differences.

Here is a practical breakdown by starting weight:

Starting Weight Average Loss at 5mg (72 Weeks) Approximate Pounds Lost
160 lbs 15% 24 lbs
180 lbs 15% 27 lbs
200 lbs 15% 30 lbs
220 lbs 15% 33 lbs
250 lbs 15% 37.5 lbs
300 lbs 15% 45 lbs

How 5mg Compares to Other Doses

Tirzepatide shows dose-dependent weight loss. Higher doses generally produce greater results, but the 5mg dose remains effective for a large number of patients: For a complete cost breakdown, see our best tirzepatide compounding pharmacies.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Tirzepatide 5mg: Weight Loss Average
  • 5mg: Average 15% body weight loss at 72 weeks
  • 10mg: Average 19.5% body weight loss at 72 weeks
  • 15mg: Average 20.9% body weight loss at 72 weeks

The gap between 5mg and the higher doses is meaningful but not as large as you might expect from tripling the dose. This suggests that a substantial portion of the drug's weight loss effect is already active at 5mg. For patients who tolerate 5mg well and prefer to minimize side effects, staying at this dose is a reasonable strategy. tirzepatide 5mg how long to stay on

What Influences Your Individual Results

Averages are useful benchmarks, but your personal outcome at 5mg will depend on several factors:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Starting BMI: Patients with higher starting BMIs tend to lose more total pounds, though the percentage may be similar across groups.
  • Diet quality: Tirzepatide reduces appetite, but what you eat still matters. Patients who prioritize protein, vegetables, and whole foods tend to outperform those who eat calorie-dense processed foods in smaller quantities.
  • Physical activity: Exercise isn't required for weight loss on tirzepatide, but it amplifies results and improves body composition (more fat lost, more muscle preserved). exercise on tirzepatide
  • Metabolic health: Insulin resistance, thyroid function, and other metabolic conditions can slow weight loss. Patients with well-managed underlying conditions tend to respond better.
  • Medication adherence: Missing doses reduces the medication's effectiveness. Consistent weekly injections are important for optimal results. tirzepatide 5mg missed dose
  • Sleep and stress: Poor sleep and chronic stress improve cortisol, which promotes fat storage and can slow weight loss.
  • Prior weight loss attempts: Patients with a history of repeated dieting may have adaptive metabolic changes that affect response to any weight loss intervention.

Weight Loss Pace at 5mg: Month by Month

Weight loss on tirzepatide 5mg isn't linear. Here is a typical trajectory:

  • Month 1 at 5mg: 5 to 10 pounds (includes the initial dose-increase effect)
  • Months 2 to 3: 3 to 6 pounds per month
  • Months 4 to 6: 2 to 4 pounds per month
  • Months 7 to 12: 1 to 2 pounds per month as you approach a new equilibrium
  • Beyond 12 months: Weight stabilization with continued medication use

If you experience a plateau lasting more than four weeks, discuss with your prescriber whether a dose increase to 7.5mg might help. tirzepatide 7.5mg what to expect

Realistic Expectations vs. Social Media Claims

Social media is filled with dramatic tirzepatide transformation stories. While these outcomes are real for some patients, they often represent the high end of the results spectrum or include patients on higher doses (10mg or 15mg).

At 5mg specifically, realistic expectations include:

  • Steady but not always dramatic weight loss
  • Noticeable clothing size changes within 2 to 3 months
  • Improved lab values (blood sugar, cholesterol, liver enzymes)
  • Better energy and mobility as weight decreases
  • A fundamentally different relationship with food and hunger

Comparing your results to viral transformation posts is rarely helpful. Focus on your own trajectory and the health improvements you can measure objectively.

Medical References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]

Frequently Asked Questions

Is 15 percent body weight loss realistic at 5mg?
Yes, but this is the trial average at 72 weeks. Some patients exceed it, others fall short. The 15 percent figure includes dietary counseling that was part of the trial protocol. Your results may differ based on lifestyle factors.
Can I lose more than the average at 5mg?
Absolutely. Some patients lose 20 percent or more at 5mg, especially those who pair the medication with structured diet and exercise programs. The averages include all participants, including those with lower adherence.
What if I have only lost 5 percent after three months at 5mg?
A 5 percent weight loss is still clinically meaningful and associated with health improvements. But if your goal requires more, your prescriber may recommend titrating to 7.5mg.
Does weight loss at 5mg slow down over time?
Yes. This is a normal pattern with all weight loss interventions. The rate slows as your body adjusts to a lower weight and your caloric needs decrease. It doesn't mean the medication stopped working.
Will I keep the weight off if I stay on 5mg?
Clinical data suggests yes. Patients who continued tirzepatide maintained their weight loss. Those who stopped regained a significant portion. Long-term use appears necessary for sustained results. long-term GLP-1 use

This article is for informational purposes only and doesn't constitute medical advice. Consult your healthcare provider for personalized weight loss guidance.

$1,000-$1,200/mo (brand) Contact provider for current pricing

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Tirzepatide 5mg: Weight Loss Average, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

Provider decision path

Use local research to choose a safer review path

Direct answer

Tirzepatide 5mg: Weight Loss Average is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

FormBlends Editorial Context

Reviewed May 14, 2026

Average weight loss on tirzepatide 5mg based on clinical trial data. Learn realistic expectations, how results compare to higher doses, and factors that influence individual outcomes. Use "Tirzepatide 5mg: Weight Loss Average" to make the conversation more specific before you choose a provider, product, or next step. The page leans into patient education and clinical context and the details behind tirzepatide, dosing, provider access. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Tirzepatide 5mg

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, 5mg so the article stays close to the question behind "Tirzepatide 5mg".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Tirzepatide 5mg from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Tirzepatide 5mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Tirzepatide 5mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Tirzepatide 5mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.